Levy O, Kuai R, Siren EMJ, Bhere D, Milton Y, Nissar N, et al. Shattering barriers toward clinically meaningful MSC therapies. Sci Adv. 2020;6(30):eaba6884.
Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53(1): e12712.
Xu J. Therapeutic applications of mesenchymal stem cells for systemic lupus erythematosus. Adv Exp Med Biol. 2018;1089:73–85.
CAS PubMed Article Google Scholar
Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15(11):1009–16.
CAS PubMed Article Google Scholar
Xu J, Lian W, Wu H, Wang X, Chen J, Yang L, et al. Improved therapeutic consistency and efficacy of mesenchymal stem cells expanded with chemically defined medium for systemic lupus erythematosus. Cell Mol Immunol. 2020;17(10):1104–6.
CAS PubMed PubMed Central Article Google Scholar
Xu J, Chen J, Li W, Lian W, Huang J, Lai B, et al. Additive therapeutic effects of mesenchymal stem cells and IL-37 for systemic Lupus Erythematosus. J Am Soc Nephrol. 2020;31(1):54–65.
CAS PubMed Article Google Scholar
Galipeau J, Sensebe L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824–33.
CAS PubMed PubMed Central Article Google Scholar
Costa LA, Eiro N, Fraile M, Gonzalez LO, Saa J, Garcia-Portabella P, et al. Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses. Cell Mol Life Sci. 2021;78(2):447–67.
CAS PubMed Article Google Scholar
Moll G, Ankrum JA, Kamhieh-Milz J, Bieback K, Ringden O, Volk HD, et al. Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines. Trends Mol Med. 2019;25(2):149–63.
Moll G, Ankrum JA, Olson SD, Nolta JA. Improved MSC minimal criteria to maximize patient safety: a call to embrace tissue factor and hemocompatibility assessment of MSC products. Stem Cells Transl Med. 2022;11(1):2–13.
PubMed PubMed Central Article Google Scholar
Jiang W, Lian W, Chen J, Li W, Huang J, Lai B, et al. Rapid identification of genome-edited mesenchymal stem cell colonies via Cas9. Biotechniques. 2019;66(5):231–4.
CAS PubMed Article Google Scholar
Xu J, Lian W, Chen J, Li W, Li L, Huang Z. Chemical-defined medium supporting the expansion of human mesenchymal stem cells. Stem Cell Res Ther. 2020;11(1):125.
CAS PubMed PubMed Central Article Google Scholar
Chan CK, Chen CC, Luppen CA, Kim JB, DeBoer AT, Wei K, et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature. 2009;457(7228):490–4.
CAS PubMed Article Google Scholar
Li Q, Hou H, Li M, Yu X, Zuo H, Gao J, et al. CD73(+) mesenchymal stem cells ameliorate myocardial infarction by promoting angiogenesis. Front Cell Dev Biol. 2021;9: 637239.
PubMed PubMed Central Article Google Scholar
Suto EG, Mabuchi Y, Toyota S, Taguchi M, Naraoka Y, Itakura N, et al. Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells. Sci Rep. 2020;10(1):15073.
CAS PubMed PubMed Central Article Google Scholar
An Z, Sabalic M, Bloomquist RF, Fowler TE, Streelman T, Sharpe PT. A quiescent cell population replenishes mesenchymal stem cells to drive accelerated growth in mouse incisors. Nat Commun. 2018;9(1):378.
PubMed PubMed Central Article Google Scholar
Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell. 2014;15(2):154–68.
CAS PubMed PubMed Central Article Google Scholar
Yue R, Zhou BO, Shimada IS, Zhao Z, Morrison SJ. Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow. Cell Stem Cell. 2016;18(6):782–96.
CAS PubMed Article Google Scholar
Miwa H, Era T. Tracing the destiny of mesenchymal stem cells from embryo to adult bone marrow and white adipose tissue via Pdgfralpha expression. Development. 2018;145(2).
Koide Y, Morikawa S, Mabuchi Y, Muguruma Y, Hiratsu E, Hasegawa K, et al. Two distinct stem cell lineages in murine bone marrow. Stem Cells. 2007;25(5):1213–21.
CAS PubMed Article Google Scholar
Xie DM, Chen Y, Liao Y, Lin W, Dai G, Lu DH, et al. Cardiac derived CD51-positive mesenchymal stem cells enhance the cardiac repair through SCF-mediated angiogenesis in mice with myocardial infarction. Front Cell Dev Biol. 2021;9: 642533.
PubMed PubMed Central Article Google Scholar
Xie DM, Li YL, Li J, Li Q, Lu G, Zhai Y, et al. CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice. Stem Cell Res Ther. 2019;10(1):331.
PubMed PubMed Central Article Google Scholar
Zang ZJ, Wang J, Chen Z, Zhang Y, Gao Y, Su Z, et al. Transplantation of CD51(+) stem leydig cells: a new strategy for the treatment of testosterone deficiency. Stem Cells. 2017;35(5):1222–32.
CAS PubMed Article Google Scholar
Jiang MH, Cai B, Tuo Y, Wang J, Zang ZJ, Tu X, et al. Characterization of Nestin-positive stem Leydig cells as a potential source for the treatment of testicular Leydig cell dysfunction. Cell Res. 2014;24(12):1466–85.
PubMed PubMed Central Article Google Scholar
Lehoczky JA, Tabin CJ. Lgr6 marks nail stem cells and is required for digit tip regeneration. Proc Natl Acad Sci USA. 2015;112(43):13249–54.
CAS PubMed PubMed Central Article Google Scholar
Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med. 2009;206(11):2483–96.
CAS PubMed PubMed Central Article Google Scholar
Maeda K, Enomoto A, Hara A, Asai N, Kobayashi T, Horinouchi A, et al. Identification of meflin as a potential marker for mesenchymal stromal cells. Sci Rep. 2016;6:22288.
CAS PubMed PubMed Central Article Google Scholar
Hara A, Kobayashi H, Asai N, Saito S, Higuchi T, Kato K, et al. Roles of the mesenchymal stromal/stem cell marker meflin in cardiac tissue repair and the development of diastolic dysfunction. Circ Res. 2019;125(4):414–30.
CAS PubMed Article Google Scholar
Yoshida Y, Kabara M, Kano K, Horiuchi K, Hayasaka T, Tomita Y, et al. Capillary-resident EphA7(+) pericytes are multipotent cells with anti-ischemic effects through capillary formation. Stem Cells Transl Med. 2020;9(1):120–30.
CAS PubMed Article Google Scholar
Yang Z, Ma S, Cao R, Liu L, Cao C, Shen Z, et al. CD49f(high) defines a distinct skin mesenchymal stem cell population capable of hair follicle epithelial cell maintenance. J Investig Dermatol. 2020;140(3):544–55 e9.
Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood. 2007;109(4):1743–51.
CAS PubMed Article Google Scholar
Suzuki K, Tanaka M, Watanabe N, Saito S, Nonaka H, Miyajima A. p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver. Gastroenterology. 2008;135(1):270–81 e3.
Meirelles Lda S, Nardi NB. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol. 2003;123(4):702–11.
Zhao H, Feng J, Ho TV, Grimes W, Urata M, Chai Y. The suture provides a niche for mesenchymal stem cells of craniofacial bones. Nat Cell Biol. 2015;17(4):386–96.
CAS PubMed PubMed Central Article Google Scholar
Shi Y, He G, Lee WC, McKenzie JA, Silva MJ, Long F. Gli1 identifies osteogenic progenitors for bone formation and fracture repair. Nat Commun. 2017;8(1):2043.
PubMed PubMed Central Article Google Scholar
Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829–34.
CAS PubMed PubMed Central Article Google Scholar
Liao Y, Li G, Zhang X, Huang W, Xie D, Dai G, et al. Cardiac Nestin(+) mesenchymal stromal cells enhance healing of ischemic heart through periostin-mediated M2 macrophage polarization. Mol Ther. 2020;28(3):855–73.
CAS PubMed PubMed Central Article Google Scholar
Jiang MH, Li G, Liu J, Liu L, Wu B, Huang W, et al. Nestin(+) kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury. Biomaterials. 2015;50:56–66.
CAS PubMed Article Google Scholar
Park D, Spencer JA, Koh BI, Kobayashi T, Fujisaki J, Clemens TL, et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell. 2012;10(3):259–72.
留言 (0)